If setting up a gliptin that has a sulfonylurea, cutting down the dose of possibly drug might be necessary to minimise the risk of hypoglycaemia (see Dosing concerns).System body weight substantially affects the pharmacokinetics of liraglutide determined by outcomes of populace pharmacokinetic analyses performed in individuals with system fat selec